DK2254598T3 - Kombination af alfa 7-nikotinagonister og antipsykotika - Google Patents

Kombination af alfa 7-nikotinagonister og antipsykotika

Info

Publication number
DK2254598T3
DK2254598T3 DK09709577.2T DK09709577T DK2254598T3 DK 2254598 T3 DK2254598 T3 DK 2254598T3 DK 09709577 T DK09709577 T DK 09709577T DK 2254598 T3 DK2254598 T3 DK 2254598T3
Authority
DK
Denmark
Prior art keywords
nicotinagonists
cycotics
alfa
combination
Prior art date
Application number
DK09709577.2T
Other languages
English (en)
Inventor
Merouane Bencherif
Gregory J Gatto
Terry Hauser
Kristen G Jordan
Sharon R Letchworth
Original Assignee
Targacept Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Targacept Inc filed Critical Targacept Inc
Application granted granted Critical
Publication of DK2254598T3 publication Critical patent/DK2254598T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
DK09709577.2T 2008-02-13 2009-02-13 Kombination af alfa 7-nikotinagonister og antipsykotika DK2254598T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US2828208P 2008-02-13 2008-02-13
PCT/US2009/034062 WO2009102962A2 (en) 2008-02-13 2009-02-13 Combination of alpha 7 nicotinic agonists and antipsychotics

Publications (1)

Publication Number Publication Date
DK2254598T3 true DK2254598T3 (da) 2013-07-29

Family

ID=40902222

Family Applications (1)

Application Number Title Priority Date Filing Date
DK09709577.2T DK2254598T3 (da) 2008-02-13 2009-02-13 Kombination af alfa 7-nikotinagonister og antipsykotika

Country Status (26)

Country Link
US (1) US20110059947A1 (da)
EP (2) EP2254598B1 (da)
JP (1) JP2011511845A (da)
KR (1) KR20100113163A (da)
CN (2) CN101977628A (da)
AU (1) AU2009214625A1 (da)
BR (1) BRPI0907570A2 (da)
CA (1) CA2715268A1 (da)
CO (1) CO6290706A2 (da)
CY (1) CY1114492T1 (da)
DK (1) DK2254598T3 (da)
EC (1) ECSP10010471A (da)
ES (1) ES2430622T3 (da)
HK (1) HK1147954A1 (da)
HR (1) HRP20130749T1 (da)
IL (1) IL207389A0 (da)
MX (1) MX2010008875A (da)
NZ (1) NZ587312A (da)
PL (1) PL2254598T3 (da)
PT (1) PT2254598E (da)
RS (1) RS52941B (da)
RU (1) RU2481123C2 (da)
SG (1) SG188144A1 (da)
SI (1) SI2254598T1 (da)
WO (1) WO2009102962A2 (da)
ZA (1) ZA201005999B (da)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8314119B2 (en) 2006-11-06 2012-11-20 Abbvie Inc. Azaadamantane derivatives and methods of use
SA08290475B1 (ar) * 2007-08-02 2013-06-22 Targacept Inc (2s، 3r)-n-(2-((3-بيردينيل)ميثيل)-1-آزا بيسيكلو[2، 2، 2]أوكت-3-يل)بنزو فيوران-2-كربوكساميد، وصور أملاحه الجديدة وطرق استخدامه
PE20131394A1 (es) 2010-09-23 2014-01-11 Abbvie Inc Monohidrato de derivados de aza-adamantano
BR112013018296A2 (pt) * 2011-01-18 2016-11-16 Targacept Inc tratamento de disfunções cognitivas em esquizofrenia
US9139576B2 (en) 2011-05-03 2015-09-22 Merck Sharp & Dohme Corp. Aminomethyl biaryl benzotriazole derivatives
CN104837820A (zh) * 2012-10-02 2015-08-12 大日本住友制药株式会社 咪唑衍生物
BR112019012573A2 (pt) 2016-12-20 2019-11-19 Lts Lohmann Therapie Systeme Ag sistema terapêutico transdérmico que contém asenapina e polissiloxano ou poli-isobutileno
MX2019007391A (es) 2016-12-20 2019-08-16 Lts Lohmann Therapie Systeme Ag Sistema terapeutico transdermico que contiene asenapina.
CN108727416B (zh) * 2017-04-20 2021-03-09 北京大学 三环杂芳香体系酰胺衍生物及其制备和用途
ES2881783T3 (es) 2017-06-26 2021-11-30 Lts Lohmann Therapie Systeme Ag Sistema terapéutico transdérmico que contiene asenapina y polímero de acrílico y silicona
CN107469087A (zh) * 2017-09-10 2017-12-15 孙永丽 用于治疗精神病的制剂
KR20210022656A (ko) 2018-06-20 2021-03-03 에르테에스 로만 테라피-시스테메 아게 아세나핀을 함유하는 경피 치료 시스템
CN117480169A (zh) * 2021-01-08 2024-01-30 艾福姆德尤股份有限公司 用于治疗与sting活性有关的疾病的化合物和组合物
DE102022114269A1 (de) 2022-06-07 2023-12-07 Rational Aktiengesellschaft Gargerät mit einem Selbstreinigungssystem sowie ein Verfahren zum Ändern von Reinigungsparametern für das Gargerät

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5597919A (en) * 1995-01-06 1997-01-28 Dull; Gary M. Pyrimidinyl or Pyridinyl alkenyl amine compounds
US5712270A (en) 1995-11-06 1998-01-27 American Home Products Corporation 2-arylamidothiazole derivatives with CNS activity
US5616716A (en) * 1996-01-06 1997-04-01 Dull; Gary M. (3-(5-ethoxypyridin)yl)-alkenyl 1 amine compounds
SE9600683D0 (sv) 1996-02-23 1996-02-23 Astra Ab Azabicyclic esters of carbamic acids useful in therapy
US5663356A (en) * 1996-04-23 1997-09-02 Ruecroft; Graham Method for preparation of aryl substituted alefinic secondary amino compounds
AR013184A1 (es) 1997-07-18 2000-12-13 Astrazeneca Ab Aminas heterociclicas espiroazobiciclicas, composicion farmaceutica, uso de dichas aminas para preparar medicamentos y metodo de tratamiento o profilaxis
CA2333951C (en) 1998-06-01 2012-02-28 Ortho-Mcneil Pharmaceutical, Inc. Method for treating neurodegenerative disorders
US6953855B2 (en) * 1998-12-11 2005-10-11 Targacept, Inc. 3-substituted-2(arylalkyl)-1-azabicycloalkanes and methods of use thereof
SE9904176D0 (sv) 1999-11-18 1999-11-18 Astra Ab New use
KR100772854B1 (ko) * 1999-12-10 2007-11-02 와이어쓰 (Ｓ)-2-(벤질아미노-메틸)-2,3,8,9-테트라하이드로-7Ｈ-1,4-디옥시노[2,3-ｅ]인돌-8-온 및 항정신병 제제의 배합물
ES2213703T5 (es) * 2000-06-27 2011-11-02 Laboratorios S.A.L.V.A.T., S.A. Carbamatos derivados de arilalquilaminas.
US6492386B2 (en) 2000-08-18 2002-12-10 Pharmacia & Upjohn Company Quinuclidine-substituted aryl compounds for treatment of disease
AU2001282874A1 (en) 2000-08-18 2002-03-04 Pharmacia And Upjohn Company Quinuclidine-substituted aryl moieties for treatment of disease (nicotinic acetylcholine receptor ligands)
US6486172B2 (en) 2000-08-18 2002-11-26 Pharmacia & Upjohn Company Quinuclidine-substituted aryl compounds for treatment of disease
WO2002017358A2 (en) 2000-08-21 2002-02-28 Pharmacia & Upjohn Company Quinuclidine-substituted heteroaryl moieties for treatment of disease (nicotinic acetylcholine receptor antagonists)
WO2002015662A2 (en) 2000-08-21 2002-02-28 Pharmacia & Upjohn Company Quinuclidine-substituted heteroaryl moieties for treatment of disease (nicotinic acetylcholine receptor antagonists
EP1311505A2 (en) 2000-08-21 2003-05-21 PHARMACIA & UPJOHN COMPANY Quinuclidine-substituted heteroaryl moieties for treatment of disease ( nicotinic acetylcholine receptor ligands )
US6554086B1 (en) * 2000-10-27 2003-04-29 Invacare Corporation Obstacle traversing wheelchair
PL362989A1 (en) 2000-12-22 2004-11-15 Almirall Prodesfarma Ag Quinuclidine carbamate derivatives and their use as m3 antagonists
US6894042B2 (en) * 2002-02-19 2005-05-17 Pharmacia & Upjohn Company Azabicyclic compounds for the treatment of disease
MXPA05005943A (es) * 2002-12-06 2005-08-18 Pharmacia & Upjohn Co Llc Sales fumarato cristalinas de furo[2,3-c]piridinilcarboxamida sustituida con 1-azabiciclo[2.2.2]octilo y composiciones y preparaciones de las mismas.
TW200502222A (en) * 2003-04-02 2005-01-16 Novartis Ag Use of 10-hydroxy-10,11-dihydrocarbamazepine derivatives for the treatment of affective disorders
WO2004099202A1 (en) * 2003-05-05 2004-11-18 Pharmacia & Upjohn Company Llc Quinuclidines substituted bentodioxine carboxamides for the treatment of neurodegenerative diseases
US7309699B2 (en) * 2003-12-22 2007-12-18 Abbott Laboratories 3-Quinuclidinyl amino-substituted biaryl derivatives
MXPA06007213A (es) * 2003-12-23 2006-08-18 Pfizer Prod Inc Combinacion terapeutica para la mejora de la cognicion y trastornos sicoticos.
JP2008533142A (ja) * 2005-03-18 2008-08-21 アボット・ラボラトリーズ α７ニューロンニコチン性受容体リガンドおよび抗精神病薬組成物

Also Published As

Publication number Publication date
ZA201005999B (en) 2011-05-25
CA2715268A1 (en) 2009-08-20
CN103143023A (zh) 2013-06-12
ECSP10010471A (es) 2010-10-30
EP2254598A2 (en) 2010-12-01
HRP20130749T1 (en) 2013-10-11
NZ587312A (en) 2011-12-22
CN101977628A (zh) 2011-02-16
KR20100113163A (ko) 2010-10-20
BRPI0907570A2 (pt) 2019-09-24
ES2430622T3 (es) 2013-11-21
EP2633868A1 (en) 2013-09-04
JP2011511845A (ja) 2011-04-14
WO2009102962A2 (en) 2009-08-20
US20110059947A1 (en) 2011-03-10
WO2009102962A3 (en) 2009-10-08
SI2254598T1 (sl) 2013-10-30
PL2254598T3 (pl) 2013-12-31
EP2254598B1 (en) 2013-07-10
CO6290706A2 (es) 2011-06-20
RU2481123C2 (ru) 2013-05-10
PT2254598E (pt) 2013-10-16
SG188144A1 (en) 2013-03-28
AU2009214625A1 (en) 2009-08-20
CY1114492T1 (el) 2016-10-05
RS52941B (en) 2014-02-28
RU2010137787A (ru) 2012-03-20
HK1147954A1 (en) 2011-08-26
IL207389A0 (en) 2010-12-30
MX2010008875A (es) 2010-08-31

Similar Documents

Publication Publication Date Title
DK2254598T3 (da) Kombination af alfa 7-nikotinagonister og antipsykotika
NO2022056I1 (no) avalglucosidase alfa
BRPI0907231A2 (pt) pirrolpirimidinas e pirrolpiridinas
DK2570467T3 (da) Sammensætninger af tetrafluorpropen og carbonhydrider
DK3338790T3 (da) Oligopeptid-forbindelser og anvendelser deraf
DK2513193T3 (da) Forbedrede blends af polyarylenethere og polyarylensulfider
BRPI0813647A2 (pt) Piperazinil oxoalquil tetrahidro-beta-carbolinas e análogos relacionados
DK2350116T3 (da) Behandling af biofilm
DK2170827T3 (da) Indolin-2-oner og aza-indolin-2-oner
DK2356093T3 (da) Carbazolforbindelser og terapeutiske anvendelser af forbindelserne
FI20075600A0 (fi) Komponentin eliniän määritys
DK2111555T3 (da) Diagnosticering af præeklampsi
DK2358714T3 (da) Alkylcyclohexylethere af dihydrotetraazabenzoazulener
DK2805746T3 (da) Alkylamido-forbindelser og anvendelser deraf
DK2280962T5 (da) Pyridazinonderivater
DK2114147T3 (da) Reduktion af bivirkninger af tramadol
DK2292592T3 (da) Sulfonamidforbindelse og anvendelse deraf
DK2334596T3 (da) Ferriphosphatbaseret sammensætning og anvendelse heraf
DK2175849T3 (da) Behandling af melanomer
DK2501381T3 (da) Behandling af atrieflimmer
DK2181065T3 (da) Partialoxidation af carbonhydrider
DK2173197T3 (da) Fremgangsmåde
DK2190451T3 (da) Behandling af atherosklerose
DK3366686T3 (da) Inhibitorer af diacylglycerol-o-acyltransferase 1 (dgat-1) og anvendelser deraf
UY3860Q (es) Reloj